Relay Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Relay Therapeutics (RLAY) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Relay Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relay Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Relay Therapeutics by Ubs Global Asset Management Americas
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $9.3M | 842k | 11.01 |
2023-09-30 | $7.3M | 866k | 8.41 |
2023-06-30 | $15M | 887k | 16.47 |
2023-03-31 | $15M | 887k | 16.47 |
2022-12-31 | $12M | 816k | 14.94 |
2022-09-30 | $19M | 830k | 22.37 |
2022-06-30 | $13M | 782k | 16.75 |
2022-03-31 | $17M | 574k | 29.93 |
2021-12-31 | $19M | 615k | 30.71 |
2021-09-30 | $7.4M | 234k | 31.53 |
2021-06-30 | $9.6M | 262k | 36.59 |
2021-03-31 | $15M | 426k | 34.57 |
2020-12-31 | $20M | 484k | 41.56 |
2020-09-30 | $11M | 255k | 42.59 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas